[{"_1":2,"_3":-5,"_4":-5},"loaderData",{"_5":6,"_7":8},"actionData","errors","root",{"_102":103,"_104":57},"item-original",{"_9":10},"item",{"_11":12,"_13":14,"_15":16,"_17":16,"_18":-5,"_19":-5,"_20":21,"_22":23,"_24":25,"_26":27,"_28":25,"_29":30,"_31":32,"_33":34,"_35":36,"_37":38,"_39":-5,"_38":40,"_41":-5,"_42":-5,"_43":-5,"_44":45,"_46":47,"_48":-5,"_49":50,"_51":52,"_53":54,"_55":36,"_56":57,"_58":-5,"_59":60,"_61":62,"_63":36,"_64":57,"_65":66},"id","ctp8i1uphsyplpuq86d4zd61h","revision",2,"title","#AACR26 Plenary Session Day2","originalTitle","summary","reason","source",{"_11":96,"_77":97,"_98":99,"_100":36,"_101":-5},"links",{"_93":94,"_66":95},"publishedAt","2026-04-18T23:49:42.000Z","discoveredAt","2026-10-22T11:08:52.472Z","timelineAt","category","opinion","tags",[],"score",60,"selected",false,"channel","x","story",{"_86":87,"_88":47,"_89":-5,"_90":-5,"_91":92},"insight","digest","conferenceAbstracts","readingMode","full","author","anu_iris","language","body",{"_81":-5,"_66":82,"_83":84,"_85":57},"outline",[],"relatedStories",[],"indexable","markdownAvailable",true,"group","conference",{"_75":76,"_77":78,"_79":-5,"_80":-5},"engagement",{"_67":68,"_69":70,"_71":72,"_73":74},"posterIsAuthor","hasTranslation","bodyLanguage","original","heat",5,"likes",4,"replies",0,"reposts",1,"slug","aacr-2026","name","AACR 2026 年会","topic","reading","zh","

#AACR26 Plenary Session Day2
#MinimalResidualDisease in Solid Tumors
Great to see Dr Chris Marine
@lab_marine
from
@vib_ccb

#MRD #Cancerreserch #Oncology #treatmentresistance

@AACR

@MassGenBrigham

@KU_Leuven

@WeillCornell

@PeterMacCC

","zhKind","translation","complete","authorName","Anu R I","handle","avatarUrl","quoted","media",[],"aihot","/items/ctp8i1uphsyplpuq86d4zd61h","https://x.com/anu_iris/status/2045651014687273217","aacr26-floor","AACR 2026 现场信号","kind","x_search","firstParty","iconUrl","changelogVersion","2026-10-23T01:25","enEditionEnabled"]